Logo image of ACT.DE

ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis

FRA:ACT - Deutsche Boerse Ag - DE000A2YNT30 - Common Stock - Currency: EUR

158  -0.6 (-0.38%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to ACT. ACT was compared to 67 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making ACT a very profitable company, without any liquidiy or solvency issues. ACT has a decent growth rate and is not valued too expensively. With these ratings, ACT could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year ACT was profitable.
ACT had a positive operating cash flow in the past year.
ACT had positive earnings in each of the past 5 years.
Of the past 5 years ACT 4 years had a positive operating cash flow.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

ACT has a Return On Assets of 11.18%. This is amongst the best in the industry. ACT outperforms 98.51% of its industry peers.
The Return On Equity of ACT (26.31%) is better than 100.00% of its industry peers.
ACT has a better Return On Invested Capital (14.95%) than 97.01% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACT is significantly above the industry average of 6.29%.
The last Return On Invested Capital (14.95%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.18%
ROE 26.31%
ROIC 14.95%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACT has a better Profit Margin (9.76%) than 82.09% of its industry peers.
ACT's Profit Margin has improved in the last couple of years.
ACT's Operating Margin of 14.16% is amongst the best of the industry. ACT outperforms 80.60% of its industry peers.
In the last couple of years the Operating Margin of ACT has grown nicely.
ACT has a Gross Margin of 64.27%. This is amongst the best in the industry. ACT outperforms 95.52% of its industry peers.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
Industry RankSector Rank
OM 14.16%
PM (TTM) 9.76%
GM 64.27%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
The number of shares outstanding for ACT has been reduced compared to 5 years ago.
ACT has a better debt/assets ratio than last year.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ACT has an Altman-Z score of 5.83. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
ACT has a Altman-Z score of 5.83. This is amongst the best in the industry. ACT outperforms 91.04% of its industry peers.
The Debt to FCF ratio of ACT is 0.85, which is an excellent value as it means it would take ACT, only 0.85 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.85, ACT belongs to the top of the industry, outperforming 97.01% of the companies in the same industry.
ACT has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.21, ACT is doing good in the industry, outperforming 71.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.85
Altman-Z 5.83
ROIC/WACC2.12
WACC7.05%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ACT has a Current Ratio of 2.48. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ACT (2.48) is better than 77.61% of its industry peers.
A Quick Ratio of 1.52 indicates that ACT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.52, ACT is in the better half of the industry, outperforming 76.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.52
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.79%, which is quite impressive.
ACT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.60% yearly.
The Revenue has been growing slightly by 1.59% in the past year.
ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%

3.2 Future

The Earnings Per Share is expected to grow by 22.19% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACT will show a small growth in Revenue. The Revenue will grow by 6.02% on average per year.
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y22.19%
Revenue Next Year3.58%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.42 indicates a quite expensive valuation of ACT.
Compared to the rest of the industry, the Price/Earnings ratio of ACT is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.50, ACT is valued at the same level.
ACT is valuated rather expensively with a Price/Forward Earnings ratio of 24.27.
The rest of the industry has a similar Price/Forward Earnings ratio as ACT.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, ACT is valued a bit cheaper.
Industry RankSector Rank
PE 28.42
Fwd PE 24.27
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

ACT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ACT is more expensive than 61.19% of the companies in the same industry.
61.19% of the companies in the same industry are more expensive than ACT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 25.92
EV/EBITDA 15.32
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 16.33% in the coming years.
PEG (NY)1.98
PEG (5Y)1.16
EPS Next 2Y13.05%
EPS Next 3Y16.33%

4

5. Dividend

5.1 Amount

ACT has a Yearly Dividend Yield of 1.21%.
Compared to an average industry Dividend Yield of 2.99, ACT is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.35, ACT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

22.58% of the earnings are spent on dividend by ACT. This is a low number and sustainable payout ratio.
ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.58%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

ALZCHEM GROUP AG

FRA:ACT (7/18/2025, 7:00:00 PM)

158

-0.6 (-0.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-30 2025-07-30
Inst Owners35.03%
Inst Owner ChangeN/A
Ins Owners40.2%
Ins Owner ChangeN/A
Market Cap1.61B
Analysts81.82
Price Target121.21 (-23.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP22.58%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)14.65%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.58%
Valuation
Industry RankSector Rank
PE 28.42
Fwd PE 24.27
P/S 2.9
P/FCF 25.92
P/OCF 15.3
P/B 7.83
P/tB 7.97
EV/EBITDA 15.32
EPS(TTM)5.56
EY3.52%
EPS(NY)6.51
Fwd EY4.12%
FCF(TTM)6.09
FCFY3.86%
OCF(TTM)10.33
OCFY6.54%
SpS54.44
BVpS20.19
TBVpS19.83
PEG (NY)1.98
PEG (5Y)1.16
Profitability
Industry RankSector Rank
ROA 11.18%
ROE 26.31%
ROCE 20.74%
ROIC 14.95%
ROICexc 17.85%
ROICexgc 18.06%
OM 14.16%
PM (TTM) 9.76%
GM 64.27%
FCFM 11.2%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 0.85
Debt/EBITDA 0.41
Cap/Depr 163.77%
Cap/Sales 7.78%
Interest Coverage 33.75
Cash Conversion 100.34%
Profit Quality 114.74%
Current Ratio 2.48
Quick Ratio 1.52
Altman-Z 5.83
F-Score7
WACC7.05%
ROIC/WACC2.12
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.79%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%20.45%
EPS Next Y14.33%
EPS Next 2Y13.05%
EPS Next 3Y16.33%
EPS Next 5Y22.19%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%-3.59%
Revenue Next Year3.58%
Revenue Next 2Y5.79%
Revenue Next 3Y8.13%
Revenue Next 5Y6.02%
EBIT growth 1Y36.94%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year48.64%
EBIT Next 3Y26.44%
EBIT Next 5Y19.11%
FCF growth 1Y19.06%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y44.69%
OCF growth 3Y34.7%
OCF growth 5Y19.23%